Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation

BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is an aggressive, highly lethal tumors and lacks of effective chemo and targeted therapies. Cell lines and animal models, even partially reflecting tumor characteristics, have limits to study ICC biology and drug response. In this work, we created an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalloni, Giuliana, Peraldo-Neia, Caterina, Sassi, Francesco, Chiorino, Giovanna, Sarotto, Ivana, Aglietta, Massimo, Leone, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750214/
https://www.ncbi.nlm.nih.gov/pubmed/26868125
http://dx.doi.org/10.1186/s12885-016-2136-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750214/
https://www.ncbi.nlm.nih.gov/pubmed/26868125
http://dx.doi.org/10.1186/s12885-016-2136-1

Ejemplares similares